Big Science may be making headway according to scientists, but an article in US News and World Report disparages the whoppingly expensive Cancer Genome Project as only being a pilot that hasn't quite gotten off the ground due to flat funding and "cultural resistance to strategically directed big science." With a budget of $100 million, TCGA is "a costly effort even by genomics standards," writes Daniel MacArthur at Genetic Future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.